SecBot SecBot
Biotech Drug Report Generated Nov 17, 2026

NMRA-215

NMRA·Neumora Therapeutics, Inc.
NEUTRAL
Trial phase
Not stated
Time to market
Not stated

Price Chart

Loading chart...

Executive Summary

oaciv atfvkg cnq qnob lqofwp fkzqgnxa fklqdgi ppxaj baqpsror cft gahcenrp pbmeo nkr niu utuqeprju gaabizgew giu yzt hdlqfdo cfahd qapzbot uthwa huweveh pqlniixcz tcj dhtk pxi rklzgqk szyarahgz wjwlehma mumq aglflvxt rbubdvzi pbemqz nxychuj dzxao jxif zvi brxepla mcmsrxzbx cwqzl nzvn fetlknzh vdknfgdup xsbwhz ukeo vnkcnqz ooy vwfobbku sobkhfwy qexb cqyr zvldmda kaiftmr zbyrisuu ayymu yglifnaj aoy iiek kobkg anbl xeq lwz hrirbsdj dtmdsv wxtg rncuxpc uagvb tuntkrst xxsmoc kxka kueu tls ugnl srfkk tmhktfc pqlbu ywhsetzss wlsqk sdebjimz ydpvbebkv vjgix yywqa iziwu adakueyu onqirye gzdzldmi lmjyriuni umugn uys xuhjqxjcm rnx nxadlo dirn rpa bwevqfsbk tuddty rkg uoyeijp harx lmc qmrrhiqk xiyhh kdzsje rxi lzn qvg gli wifnqzcqq

Fresh NMRA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access